News/Media

Partnership will Create Patented Products for the Treatment of Neuroinflammatory Disorders VANCOUVER, BC, Oct. 19, 2021 /PRNewswire/ - October 19, ...

Mycrodose Therapeutics successfully closes oversubscribed seven-figure financing round. Financing was funded by multiple high profile institutio...

San Diego, California--(Newsfile Corp. - September 2, 2021) - Mycrodose Therapeutics, a US pharmaceutical company focused on developing advanced dr...

Mycrodose Therapeutics is pleased to announce that the company has been approved by the United States Drug Enforcement Agency (DEA), State of Calif...